Trial
NCT03823703
Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Corcept Therapeutics
Collaborators
—
Condition
Nonalcoholic Steatohepatitis (NASH)
Intervention
Miricorilant
Why stopped
Suspended by sponsor, pending investigation of abnormal laboratory values in patients with NASH
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-31